Institutional shares held 184 Million
917K calls
91.6K puts
Total value of holdings $3.19B
$16M calls
$1.59M puts
Market Cap $3.48B
196,356,992 Shares Out.
Institutional ownership 93.48%
# of Institutions 319


Latest Institutional Activity in ADMA

Top Purchases

Q3 2024
State Street Corp Shares Held: 13M ($230M)
Q3 2024
Morgan Stanley Shares Held: 8.6M ($152M)
Q3 2024
Vanguard Group Inc Shares Held: 18.1M ($321M)
Q3 2024
Lord, Abbett & Co. LLC Shares Held: 3.09M ($54.8M)
Q3 2024
Goldman Sachs Group Inc Shares Held: 2.61M ($46.3M)

Top Sells

Q3 2024
Magnetar Financial LLC Shares Held: 40.1K ($710K)
Q3 2024
Nuveen Asset Management, LLC Shares Held: 6.58M ($117M)
Q3 2024
American Century Companies Inc Shares Held: 4.21M ($74.6M)
Q3 2024
Perceptive Advisors LLC Shares Held: 1.06M ($18.8M)
Q3 2024
Voloridge Investment Management, LLC Shares Held: 218K ($3.86M)

About ADMA

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.


Insider Transactions at ADMA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1.77M Shares
From 14 Insiders
Grant, award, or other acquisition 967K shares
Exercise of conversion of derivative security 805K shares
Sell / Disposition
3.27M Shares
From 12 Insiders
Open market or private sale 2.52M shares
Payment of exercise price or tax liability 277K shares
Bona fide gift 10K shares
Other acquisition or disposition 460K shares

Track Institutional and Insider Activities on ADMA

Follow ADMA BIOLOGICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA